Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$160.93$242.80
1-Month Range
Month up 5.8%
$222.84$236.98
Daily Price Range
Day down -0.1%
$234.11$237.95
Volume
vs 4M avg
1M4M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$165.9B
Short % of Float—
Employees—
Sales$24,568M
Shares Outstanding703,530,815
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.dhr.com
Danaher Corp — Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technolog….· via yahoo
Warnings
1 signal
Live
- No material red flags detected in fundamental screen
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
72
Growth
83
Quality
62
Sentiment
94
Insider Sent.
0
Piotroski F
6
Altman Z
4.6
Consensus rating unavailable — no analyst coverage on file for DHR.
Price targets unavailable — no 12-month targets on file for DHR.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on DHR, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:08 PM UTC